MOONLAKE IMMUNOTHERAPEUTICS (MLTX) Top Institutional Shareholders
MOONLAKE IMMUNOTHERAPEUTICS (MLTX) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended March 31, 2026. The institutional investors covered on this page collectively reported approximately $1.12B in MLTX holdings during the latest filing period.
Bvf Inc/Il is currently the largest disclosed institutional shareholder of MLTX tracked by InsiderSet, reporting ownership valued at approximately $298.26M in its March 31, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $307.06M, representing an estimated gain of +2.95% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 68% of the total disclosed MLTX value among the investors covered in this analysis. Major shareholders include Bvf Inc/Il, Deep Track Capital, Lp, Cormorant Asset Management, Lp, and several other long-term asset managers with concentrated positions in MOONLAKE IMMUNOTHERAPEUTICS (MLTX).
This page ranks the largest institutional MLTX shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
144
Total Reported Value
$1.12B
Largest Holder
Bvf Inc/Il
Largest Position
$298.26M
Insider Transactions (90d)
0
Latest Filing Quarter
Q1 2026
New Institutional Positions
167
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Bvf Inc/Il | 9.50% | 16,001,284 | $298,263,934 | $307,064,640 | +$8,800,706 | +2.95% | |
| Deep Track Capital, Lp | 2.47% | 6,408,863 | $119,461,206 | $122,986,081 | +$3,524,875 | +2.95% | |
| Cormorant Asset Management, Lp | 4.21% | 4,480,433 | $83,515,271 | $85,979,509 | +$2,464,238 | +2.95% | |
| Janus Henderson Group Plc | 0.03% | 3,451,628 | $64,303,830 | $66,236,741 | +$1,932,911 | +3.01% | |
| D. E. Shaw & Co., Inc. | 0.04% | 2,390,661 | $44,561,921 | $45,876,785 | +$1,314,864 | +2.95% | |
| Mpm Bioimpact Llc | 2.61% | 1,811,082 | $33,758,568 | $34,754,664 | +$996,096 | +2.95% | |
| Weiss Asset Management Lp | 0.59% | 1,708,328 | $31,843,234 | $32,782,814 | +$939,580 | +2.95% | |
| Logos Global Management Lp | 1.44% | 1,500,000 | $27,960,000 | $28,785,000 | +$825,000 | +2.95% | |
| Point72 Asset Management, L.P. | 0.04% | 1,368,518 | $25,509,176 | $26,261,860 | +$752,684 | +2.95% | |
| Citadel Advisors Llc | 0.02% | 1,323,728 | $24,674,290 | $25,402,340 | +$728,050 | +2.95% | |
| Goldman Sachs Group Inc | 0.00% | 1,130,233 | $21,067,543 | $21,689,171 | +$621,628 | +2.95% | |
| Two Sigma Investments, Lp | 0.02% | 1,122,312 | $20,919,896 | $21,537,167 | +$617,271 | +2.95% | |
| Balyasny Asset Management L.P. | 0.04% | 1,065,610 | $19,862,970 | $20,449,056 | +$586,086 | +2.95% | |
| Blackrock, Inc. | 0.00% | 1,021,851 | $19,047,302 | $19,609,321 | +$562,019 | +2.95% | |
| Vivo Capital, Llc | 1.56% | 1,000,000 | $18,640,000 | $19,190,000 | +$550,000 | +2.95% | |
| Candriam S.C.A. | 0.08% | 818,126 | $15,249,869 | $15,699,838 | +$449,969 | +2.95% | |
| Bank Of America Corp | 0.00% | 724,794 | $13,510,160 | $13,908,797 | +$398,637 | +2.95% | |
| Morgan Stanley | 0.00% | 614,482 | $11,453,948 | $11,791,910 | +$337,962 | +2.95% | |
| Holocene Advisors, Lp | 0.03% | 600,000 | $11,184,000 | $11,514,000 | +$330,000 | +2.95% | |
| Millennium Management Llc | 0.01% | 576,092 | $10,738,355 | $11,055,205 | +$316,850 | +2.95% | |
| Great Point Partners Llc | 2.28% | 500,000 | $9,320,000 | $9,595,000 | +$275,000 | +2.95% | |
| Jefferies Financial Group Inc. | 0.11% | 500,000 | $9,320,000 | $9,595,000 | +$275,000 | +2.95% | |
| Trexquant Investment Lp | 0.07% | 495,336 | $9,233,063 | $9,505,498 | +$272,435 | +2.95% | |
| Adar1 Capital Management, Llc | 0.51% | 457,137 | $8,521,034 | $8,772,459 | +$251,425 | +2.95% | |
| Jane Street Group, Llc | 0.01% | 453,625 | $8,455,571 | $8,705,064 | +$249,493 | +2.95% | |
| Casdin Capital, Llc | 0.64% | 450,000 | $8,388,000 | $8,635,500 | +$247,500 | +2.95% | |
| Longaeva Partners L.P. | 0.37% | 410,000 | $7,642,400 | $7,867,900 | +$225,500 | +2.95% | |
| Voleon Capital Management Lp | 0.15% | 373,021 | $6,953,111 | $7,158,273 | +$205,162 | +2.95% | |
| Susquehanna International Group, Llp | 0.01% | 341,424 | $6,364,143 | $6,551,927 | +$187,784 | +2.95% | |
| Jump Financial, Llc | 0.09% | 325,968 | $6,076,044 | $6,255,326 | +$179,282 | +2.95% | |
| Walleye Capital Llc | 0.04% | 320,472 | $5,973,598 | $6,149,858 | +$176,260 | +2.95% | |
| First Turn Management, Llc | 0.66% | 315,563 | $5,882,094 | $6,055,654 | +$173,560 | +2.95% | |
| Renaissance Technologies LLC | Jim Simons | 0.01% | 276,772 | $5,159,030 | $5,311,255 | +$152,225 | +2.95% |
| Boxer Capital Management, Llc | 0.67% | 275,000 | $5,126,000 | $5,277,250 | +$151,250 | +2.95% | |
| Susquehanna Portfolio Strategies, Llc | 0.07% | 253,974 | $4,734,075 | $4,873,761 | +$139,686 | +2.95% | |
| Bnp Paribas Financial Markets | 0.00% | 239,838 | $4,470,580 | $4,602,491 | +$131,911 | +2.95% | |
| Rhenman & Partners Asset Management Ab | 0.55% | 239,500 | $4,464,280 | $4,596,005 | +$131,725 | +2.95% | |
| Granahan Investment Management, Llc | 0.20% | 220,600 | $4,111,984 | $4,233,314 | +$121,330 | +2.95% | |
| Exome Asset Management Llc | 2.36% | 215,376 | $4,014,609 | $4,133,065 | +$118,456 | +2.95% | |
| Highvista Strategies Llc | 1.00% | 193,955 | $3,615,321 | $3,721,996 | +$106,675 | +2.95% | |
| Acuta Capital Partners, Llc | 2.54% | 191,760 | $3,574,406 | $3,679,874 | +$105,468 | +2.95% | |
| Congress Asset Management Co | 0.02% | 178,555 | $3,328,265 | $3,426,470 | +$98,205 | +2.95% | |
| Kalehua Capital Management Llc | 2.76% | 175,734 | $3,275,682 | $3,372,335 | +$96,653 | +2.95% | |
| Ishara Investments Lp | 3.28% | 174,250 | $3,248,020 | $3,343,858 | +$95,838 | +2.95% | |
| Rice Hall James & Associates, Llc | 0.17% | 167,766 | $3,127,158 | $3,219,430 | +$92,272 | +2.95% | |
| Readystate Asset Management Lp | 0.16% | 144,238 | $2,688,596 | $2,767,927 | +$79,331 | +2.95% | |
| Fmr Llc | 0.00% | 143,559 | $2,675,936 | $2,754,897 | +$78,961 | +2.95% | |
| Td Asset Management Inc | 0.00% | 142,706 | $2,660,040 | $2,738,528 | +$78,488 | +2.95% | |
| Invesco Ltd. | 0.00% | 139,574 | $2,601,660 | $2,678,425 | +$76,765 | +2.95% | |
| J. Goldman & Co Lp | 0.12% | 136,900 | $2,551,816 | $2,627,111 | +$75,295 | +2.95% |
Frequently asked questions about MLTX
Who owns the most MLTX stock?
The largest holders of MLTX are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for MOONLAKE IMMUNOTHERAPEUTICS (MLTX).
Is MLTX widely held by superinvestors?
Many widely followed stocks like MLTX appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly MLTX is represented among the institutional managers we track.
What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?
Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.